The recommendation of NNVC is no longer on Allan's public blog, http://allallan.blogspot.com — but there is no recommendation of any other stock there either.
A very good summary of the company and it’s prospects over the next two years. From a presentation by Dr. Eugene Seymour, CEO Nanoviricides, January, 2013.
This was followed by the slides from Dr. Seymour's excellent presentation in San Francisco, Jan 3, 2013.
In response to a Jan 26, 2013 question about NNVC posted by a subscriber, he replied:
By ALLAN POSTED: January 26, 2013
I posted (free, no password protection) this NNVC Update for everyone who bought the stock upon my description and opinion of it’s potential. Addressing multi-billion dollar markets with a standard-of-care treatment would likely result in a multi-billion dollar market cap. When I do the math, I see a $75M company worth at least 10X-20X it’s current stock price. There are no guarantees in this business, just risk and reward.
For what it's worth, Allan had a number of times said that NNVC was one of his rare buy and hold stocks and that he had decided not to trade it based on his trend following charts. I don't know that he still holds his NNVC, but based on the Jan 26 comment I would guess that he does.
In the comment section Alan responded to Douglas:"Not at all, Doug. I posted a NNVC Update on the Allantrends web site last week. It's free, no password needed. Nanoviricides is still an under-the-radar blockbuster company and stock.
As for the NNVC blurb, it was a little dated and needed to refreshed. I just took the old text down while working on a new piece. It will be up soon."